Regulation of Metastasis in Ewing Sarcoma

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Oct 14

PMID 36230825

Authors

Mingli Li

Chunwei Chen

Affiliations

Soon will be listed here.

Abstract

Ewing sarcoma (EwS) is a type of bone and soft tissue tumor in children and adolescents. Over 85% of cases are caused by the expression of fusion protein EWSR1-FLI1 generated by chromosome translocation. Acting as a potent chimeric oncoprotein, EWSR1-FLI1 binds to chromatin, changes the epigenetic states, and thus alters the expression of a large set of genes. Several studies have revealed that the expression level of EWSR1-FLI1 is variable and dynamic within and across different EwS cell lines and primary tumors, leading to tumoral heterogeneity. Cells with high EWSR1-FLI1 expression (EWSR1-FLI1-high) proliferate in an exponential manner, whereas cells with low EWSR1-FLI1 expression (EWSR1-FLI1-low) tend to have a strong propensity to migrate, invade, and metastasize. Metastasis is the leading cause of cancer-related deaths. The continuous evolution of EwS research has revealed some of the molecular underpinnings of this dissemination process. In this review, we discuss the molecular signatures that contribute to metastasis.

Citing Articles

Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas.

Petrescu D, Yustein J, Dasgupta A Front Oncol. 2024; 14:1388484.

PMID: 39091911 PMC: 11291195. DOI: 10.3389/fonc.2024.1388484.

Liquid-liquid phase separation in diseases.

Zhang X, Yuan L, Zhang W, Zhang Y, Wu Q, Li C MedComm (2020). 2024; 5(7):e640.

PMID: 39006762 PMC: 11245632. DOI: 10.1002/mco2.640.

Prognostic value of and infiltrating immune cells in Ewing sarcoma.

Wen J, Yi L, Wan L, Dong X Heliyon. 2023; 9(9):e19357.

PMID: 37662777 PMC: 10474439. DOI: 10.1016/j.heliyon.2023.e19357.

Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.

Gong H, Xue B, Ru J, Pei G, Li Y Cancers (Basel). 2023; 15(16).

PMID: 37627063 PMC: 10452796. DOI: 10.3390/cancers15164035.

References

Kamura S, Matsumoto Y, Fukushi J, Fujiwara T, Iida K, Okada Y . Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. Br J Cancer. 2010; 103(3):370-81. PMC: 2920026. DOI: 10.1038/sj.bjc.6605775. View

Lawlor E, Sorensen P . Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?. Crit Rev Oncog. 2015; 20(3-4):155-71. PMC: 4671490. DOI: 10.1615/critrevoncog.2015013553. View

Chaturvedi A, Hoffman L, Welm A, Lessnick S, Beckerle M . The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma. Genes Cancer. 2012; 3(2):102-16. PMC: 3463921. DOI: 10.1177/1947601912457024. View

Agelopoulos K, Richter G, Schmidt E, Dirksen U, von Heyking K, Moser B . Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma. Clin Cancer Res. 2015; 21(21):4935-46. DOI: 10.1158/1078-0432.CCR-14-2744. View

Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

Steinestel K, Trautmann M, Jansen E, Dirksen U, Rehkamper J, Mikesch J . Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma. Mol Oncol. 2019; 14(2):248-260. PMC: 6998388. DOI: 10.1002/1878-0261.12610. View

Mendoza-Naranjo A, El-Naggar A, Wai D, Mistry P, Lazic N, Rojas Ayala F . ERBB4 confers metastatic capacity in Ewing sarcoma. EMBO Mol Med. 2013; 5(7):1087-102. PMC: 3721475. DOI: 10.1002/emmm.201202343. View

van der Schaft D, Hillen F, Pauwels P, Kirschmann D, Castermans K, Oude Egbrink M . Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res. 2005; 65(24):11520-8. DOI: 10.1158/0008-5472.CAN-05-2468. View

Strizzi L, Muraro R, Vianale G, Natoli C, Talone L, Catalano A . Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival. J Pathol. 2002; 197(2):218-23. DOI: 10.1002/path.1125. View

10.

Sanchez-Molina S, Figuerola-Bou E, Blanco E, Sanchez-Jimenez M, Taboas P, Gomez S . RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Sci Adv. 2020; 6(43). PMC: 7608835. DOI: 10.1126/sciadv.aba3058. View

11.

Monument M, Johnson K, Grossmann A, Schiffman J, Randall R, Lessnick S . Microsatellites with macro-influence in ewing sarcoma. Genes (Basel). 2014; 3(3):444-60. PMC: 3899989. DOI: 10.3390/genes3030444. View

12.

Mackintosh C, Ordonez J, Garcia-Dominguez D, Sevillano V, Llombart-Bosch A, Szuhai K . 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2011; 31(10):1287-98. DOI: 10.1038/onc.2011.317. View

13.

Gangwal K, Close D, Enriquez C, Hill C, Lessnick S . Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma. Genes Cancer. 2010; 1(2):177-187. PMC: 2935179. DOI: 10.1177/1947601910361495. View

14.

Johnson K, Taslim C, Saund R, Lessnick S . Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. PLoS One. 2017; 12(11):e0186275. PMC: 5665490. DOI: 10.1371/journal.pone.0186275. View

15.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

16.

Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O . The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One. 2009; 4(3):e4932. PMC: 2654724. DOI: 10.1371/journal.pone.0004932. View

17.

Iacobelli S, Sismondi P, Giai M, DEgidio M, Tinari N, Amatetti C . Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer. 1994; 69(1):172-6. PMC: 1968766. DOI: 10.1038/bjc.1994.29. View

18.

Pedersen E, Menon R, Bailey K, Thomas D, Van Noord R, Tran J . Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States. Cancer Res. 2016; 76(17):5040-53. PMC: 5010452. DOI: 10.1158/0008-5472.CAN-15-3422. View

19.

Somasekharan S, Stoynov N, Rotblat B, Leprivier G, Galpin J, Ahern C . Identification and quantification of newly synthesized proteins translationally regulated by YB-1 using a novel Click-SILAC approach. J Proteomics. 2012; 77:e1-10. DOI: 10.1016/j.jprot.2012.08.019. View

20.

Li M, Chen C . Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities. Biomedicines. 2022; 10(6). PMC: 9219675. DOI: 10.3390/biomedicines10061325. View